CN Patent

CN105748499B — 两个抗病毒化合物的联用制剂

Assigned to Gilead Sciences Inc · Expires 2018-12-28 · 7y expired

What this patent protects

本发明公开了含有治疗有效量的ledipasvir和治疗有效量的sofosbuvir的药学组合物，其中ledipasvir基本上为非晶体，sofosbuvir基本上为晶体。

USPTO Abstract

本发明公开了含有治疗有效量的ledipasvir和治疗有效量的sofosbuvir的药学组合物，其中ledipasvir基本上为非晶体，sofosbuvir基本上为晶体。

Drugs covered by this patent

Patent Metadata

Patent number: CN105748499B
Jurisdiction: CN
Classification: —
Expires: 2018-12-28
Drug substance claim: No
Drug product claim: No
Assignee: Gilead Sciences Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.